Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To modulate transcription, regulatory factors communicate with basal transcription factors and/or RNA polymerases in a variety of ways. Previously, it has been reported that RNA polymerase II subunit 5 (RPB5) is one of the targets of hepatitis B virus X protein (HBx) and that both HBx and RPB5 specifically interact with general transcription factor IIB (TFIIB), implying that RPB5 is one of the communicating subunits of RNA polymerase II involved in transcriptional regulation. In this context, we screened for a host protein(s) that interacts with RPB5. By far-Western blot screening, we cloned a novel gene encoding a 508-amino-acid-residue RPB5-binding protein from a HepG2 cDNA library and designated it
RPB5-mediating protein
(
RMP
). Expression of
RMP
mRNA was detected ubiquitously in various tissues. Bacterially expressed recombinant
RMP
strongly bound RPB5 but neither HBx nor
TATA-binding protein
in vitro. Endogenous
RMP
was immunologically detected interacting with assembled RPB5 in RNA polymerase in mammalian cells. The central part of
RMP
is responsible for RPB5 binding, and the
RMP
-binding region covers both the TFIIB- and HBx-binding sites of RPB5. Overexpression of
RMP
, but not mutant
RMP
lacking the RPB5-binding region, inhibited HBx transactivation of reporters with different HBx-responsive cis elements in transiently transfected cells. The repression by
RMP
was counteracted by HBx in a dose-dependent manner. Furthermore,
RMP
has an inhibitory effect on transcriptional activation by VP16 in the absence of HBx. These results suggest that
RMP
negatively modulates RNA polymerase II function by binding to RPB5 and that HBx counteracts the negative role of
RMP
on transcription indirectly by interacting with RPB5.
...
PMID:RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. 981 40